History | Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer | Guidance | NICE

History

Documents created during the development process.

Final appraisal determination

Final appraisal determination
Committee papers (PDF 1.38 MB)

Published:

17 November 2016
Final appraisal determination document (PDF 303 KB)

Published:

17 November 2016
Committee papers Presentation slides (PDF 468 KB)

Published:

17 November 2016

Draft guidance

Draft guidance
Committee papers (PDF 9.54 MB)

Published:

20 May 2016
Appraisal consultation document (PDF 313 KB)

Published:

20 May 2016

Invitation to participate

Final matrix (PDF 99 KB)

Published:

01 December 2015
NICE's response to comments on the draft scope and provisional matrix (PDF 261 KB)

Published:

01 December 2015
Equality impact assessment (Scoping) (PDF 121 KB)

Published:

01 December 2015
Final scope (PDF 102 KB)

Published:

02 December 2015

Draft scope documents

Draft scope (pre-referral) (PDF 109 KB)

Published:

26 November 2015
Provisional matrix (pre-referral) (PDF 178 KB)

Published:

26 November 2015